HI-Bio’s $95 Million Series B Financing Round

Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Teylor AG’s Partnership With Taurus SA

Allen & Overy acted as Luxembourg counsel, while Schellenberg Wittmer Ltd. provided the Swiss law advice. Teylor AG, a Swiss fintech lending platform, has successfully executed...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here